As I understand it management have said they'd put out an update, but not expecting any deals.
Mind you, I think there may be some announcements over Q1 that could be really interesting.
For example:
* The Jansen deal will have rolled over the 12 mths, so will there be a payment due? * Pfizer option around the in vivo trial wraps up end of Dec, so deal or no deal should be clear early in the year, and * I think the Roche deal option expires early in the year, Feb?, so something on that too.
So, three of the 4 existing deals should have news flow, one way or the other in Q1. Then there are the much debated new deals that may come through?
Personally, I'm looking to the new year and hope that 2013 is a little better than 2012 !!
PYC Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)